Close log in window
Enhanced evidence collection methodologies can improve approval rates and ensure reimbursement. Pharma companies should build an internal, c...
Pharma is waking up to the potential of social media to enhance existing RWD sources and to offer altogether new insights in rare disease an...
Post pandemic, pharma and regulators are both working to accelerate the transformative power of electronic filing
The FDA is developing guidelines that will help pharma accelerate its adoption of RWE, this is what the industry should know